Symbol:
Slc6a9
Name:
solute carrier family 6 (neurotransmitter transporter, glycine), member 9
RGD ID:
732097
MGI Page
MGI
Description:
Enables glycine:sodium symporter activity. Involved in several processes, including glycine import across plasma membrane; positive regulation of biosynthetic process; and regulation of glycinergic synaptic transmission. Acts upstream of or within glycine secretion, neurotransmission. Located in plasma membrane. Is expressed in several structures, including central nervous system; eye; genitourinary system; gut; and liver and biliary system. Used to study glycine encephalopathy. Orthologous to human SLC6A9 (solute carrier family 6 member 9).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
glycine transporter 1; Glyt; Glyt-; Glyt-1; Glyt1; sodium- and chloride-dependent glycine transporter 1; solute carrier family 6 member 9
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC6A9 (solute carrier family 6 member 9) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SLC6A9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc6a9 (solute carrier family 6 member 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Slc6a9 (solute carrier family 6 member 9)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
SLC6A9 (solute carrier family 6 member 9)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
slc6a9 (solute carrier family 6 member 9)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Drosophila melanogaster (fruit fly):
GlyT
Alliance
DIOPT (Ensembl Compara|OrthoFinder|OrthoInspector|PANTHER)
Xenopus tropicalis (tropical clawed frog):
slc6a9
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 117,692,240 - 117,726,502 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 117,691,703 - 117,732,395 (+) Ensembl GRCm39 Ensembl GRCm38 4 117,835,258 - 117,869,305 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 117,834,506 - 117,875,198 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 117,507,863 - 117,541,910 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 117,333,190 - 117,367,237 (+) NCBI MGSCv36 mm8 Celera 4 116,550,328 - 116,584,414 (+) NCBI Celera Cytogenetic Map 4 D1 NCBI cM Map 4 53.62 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc6a9 Mouse (+)-schisandrin B multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC6A9 mRNA] CTD PMID:31150632 Slc6a9 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A9 mRNA CTD PMID:36331819 Slc6a9 Mouse 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression ISO Slc6a9 (Rattus norvegicus) 6480464 2 more ... CTD PMID:19414516 Slc6a9 Mouse 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC6A9 mRNA CTD PMID:22206623 Slc6a9 Mouse 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLC6A9 mRNA CTD PMID:17942748 Slc6a9 Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA CTD PMID:17942748 Slc6a9 Mouse 17beta-estradiol multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC6A9 mRNA CTD PMID:30165855 Slc6a9 Mouse 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SLC6A9 mRNA CTD PMID:39298647 Slc6a9 Mouse 17beta-estradiol increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Estradiol results in increased expression of SLC6A9 mRNA CTD PMID:32145629 Slc6a9 Mouse 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 2 more ... CTD PMID:27291303 Slc6a9 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA CTD PMID:17942748 Slc6a9 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A9 mRNA CTD PMID:33387578 Slc6a9 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A9 mRNA CTD PMID:21570461 and PMID:24680724 Slc6a9 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A9 mRNA CTD PMID:21215274 Slc6a9 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A9 mRNA CTD PMID:19933214 Slc6a9 Mouse 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 Slc6a9 Mouse 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of SLC6A9 mRNA CTD PMID:19812364 Slc6a9 Mouse 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 Slc6a9 Mouse 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bisphenol S results in increased methylation of SLC6A9 exon CTD PMID:33297965 Slc6a9 Mouse 4,4'-sulfonyldiphenol multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SLC6A9 mRNA CTD PMID:36041667 Slc6a9 Mouse 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of SLC6A9 mRNA CTD PMID:39298647 Slc6a9 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SLC6A9 mRNA CTD PMID:28973697 Slc6a9 Mouse 6-propyl-2-thiouracil decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SLC6A9 mRNA CTD PMID:24780913 and PMID:30047161 Slc6a9 Mouse 8-Br-cAMP increases expression ISO SLC6A9 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC6A9 mRNA CTD PMID:20147733 Slc6a9 Mouse acetamide decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 acetamide results in decreased expression of SLC6A9 mRNA CTD PMID:31881176 Slc6a9 Mouse adefovir pivoxil decreases expression ISO SLC6A9 (Homo sapiens) 6480464 adefovir dipivoxil results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC6A9 mRNA CTD PMID:19770486 Slc6a9 Mouse aflatoxin B1 increases methylation ISO SLC6A9 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC6A9 intron CTD PMID:30157460 Slc6a9 Mouse Aflatoxin B2 alpha increases methylation ISO SLC6A9 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SLC6A9 intron CTD PMID:30157460 Slc6a9 Mouse amitrole decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of SLC6A9 mRNA CTD PMID:30047161 Slc6a9 Mouse amphetamine affects response to substance EXP 6480464 SLC6A9 protein affects the susceptibility to Amphetamine CTD PMID:15159536 Slc6a9 Mouse aristolochic acid A decreases expression ISO SLC6A9 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC6A9 mRNA CTD PMID:33212167 Slc6a9 Mouse arsane affects methylation ISO SLC6A9 (Homo sapiens) 6480464 Arsenic affects the methylation of SLC6A9 gene CTD PMID:25304211 Slc6a9 Mouse arsenic atom affects methylation ISO SLC6A9 (Homo sapiens) 6480464 Arsenic affects the methylation of SLC6A9 gene CTD PMID:25304211 Slc6a9 Mouse arsenous acid increases expression ISO SLC6A9 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC6A9 mRNA CTD PMID:27829220 Slc6a9 Mouse atrazine decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Atrazine results in decreased expression of SLC6A9 mRNA CTD PMID:36841081 Slc6a9 Mouse benzamide multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 benzamide analog binds to and results in decreased activity of SLC6A9 protein CTD PMID:18355687 Slc6a9 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SLC6A9 mRNA CTD PMID:21569818 Slc6a9 Mouse benzo[a]pyrene affects methylation ISO SLC6A9 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC6A9 intron CTD PMID:30157460 Slc6a9 Mouse benzo[a]pyrene multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with dibenzo(a and l)pyrene] results in increased expression of SLC6A9 mRNA CTD PMID:17690111 Slc6a9 Mouse benzo[a]pyrene decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC6A9 mRNA CTD PMID:22316170 Slc6a9 Mouse beta-lapachone decreases expression ISO SLC6A9 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of SLC6A9 mRNA CTD PMID:38218311 Slc6a9 Mouse bis(2-chloroethyl) sulfide decreases expression EXP 6480464 Mustard Gas results in decreased expression of SLC6A9 mRNA CTD PMID:15674843 Slc6a9 Mouse bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA CTD PMID:19850644 Slc6a9 Mouse bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA] CTD PMID:19850644 Slc6a9 Mouse bisphenol A increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:26982218 and PMID:32145629 Slc6a9 Mouse bisphenol A multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SLC6A9 mRNA CTD PMID:36041667 Slc6a9 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:34585602 Slc6a9 Mouse bisphenol A increases expression ISO SLC6A9 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC6A9 mRNA CTD PMID:29275510 Slc6a9 Mouse bisphenol A decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SLC6A9 mRNA CTD PMID:25181051 Slc6a9 Mouse bisphenol F decreases expression EXP 6480464 bisphenol F results in decreased expression of SLC6A9 mRNA CTD PMID:38685157 Slc6a9 Mouse bisphenol F multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SLC6A9 mRNA CTD PMID:36041667 Slc6a9 Mouse butan-1-ol multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC6A9 mRNA CTD PMID:29432896 Slc6a9 Mouse cadmium dichloride decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of SLC6A9 mRNA CTD PMID:33453195 Slc6a9 Mouse cadmium dichloride decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 and PMID:38382870 Slc6a9 Mouse cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of SLC6A9 mRNA CTD PMID:21542829 Slc6a9 Mouse cannabidiol increases expression ISO SLC6A9 (Homo sapiens) 6480464 Cannabidiol results in increased expression of SLC6A9 mRNA CTD PMID:31518892 Slc6a9 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 Slc6a9 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 Slc6a9 Mouse casticin decreases expression EXP 6480464 casticin results in decreased expression of SLC6A9 mRNA CTD PMID:28444820 Slc6a9 Mouse chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of SLC6A9 mRNA CTD PMID:33711761 Slc6a9 Mouse chloroacetaldehyde decreases expression ISO SLC6A9 (Homo sapiens) 6480464 chloroacetaldehyde results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SLC6A9 mRNA CTD PMID:34289071 Slc6a9 Mouse choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 Slc6a9 Mouse cidofovir anhydrous decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Cidofovir results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of SLC6A9 mRNA CTD PMID:18353800 Slc6a9 Mouse cisplatin decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Cisplatin results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse cisplatin multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC6A9 mRNA CTD PMID:27392435 Slc6a9 Mouse clobetasol increases expression EXP 6480464 Clobetasol results in increased expression of SLC6A9 mRNA CTD PMID:27462272 Slc6a9 Mouse clodronic acid decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Clodronic Acid results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse clofibric acid affects expression ISO Slc6a9 (Rattus norvegicus) 6480464 Clofibric Acid affects the expression of SLC6A9 mRNA CTD PMID:17602206 Slc6a9 Mouse cobalt dichloride increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of SLC6A9 mRNA CTD PMID:24386269 Slc6a9 Mouse copper atom multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 Slc6a9 Mouse copper(0) multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 Slc6a9 Mouse coumarin increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 coumarin results in increased expression of SLC6A9 mRNA CTD PMID:18480146 Slc6a9 Mouse Cuprizon decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of SLC6A9 mRNA CTD PMID:27523638 Slc6a9 Mouse Cuprizon increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of SLC6A9 mRNA CTD PMID:26577399 Slc6a9 Mouse cyclosporin A increases expression ISO SLC6A9 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse cyclosporin A increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Cyclosporine results in increased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse DDE decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC6A9 mRNA CTD PMID:38568856 Slc6a9 Mouse decabromodiphenyl ether increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in increased expression of SLC6A9 mRNA CTD PMID:23640034 and PMID:23914054 Slc6a9 Mouse dexamethasone decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of SLC6A9 mRNA CTD PMID:25047013 Slc6a9 Mouse diarsenic trioxide increases expression ISO SLC6A9 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC6A9 mRNA CTD PMID:27829220 Slc6a9 Mouse diazinon increases methylation ISO SLC6A9 (Homo sapiens) 6480464 Diazinon results in increased methylation of SLC6A9 gene CTD PMID:22964155 Slc6a9 Mouse dibenzo[a,l]pyrene multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with dibenzo(a and l)pyrene] results in increased expression of SLC6A9 mRNA CTD PMID:17690111 Slc6a9 Mouse dibutyl phthalate decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of SLC6A9 mRNA CTD PMID:21266533 Slc6a9 Mouse dichlorine multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA CTD PMID:18636392 Slc6a9 Mouse diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of SLC6A9 mRNA CTD PMID:35537566 Slc6a9 Mouse dioxygen multiple interactions EXP 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SLC6A9 mRNA] CTD PMID:22629407 Slc6a9 Mouse dioxygen decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SLC6A9 mRNA CTD PMID:22629407 Slc6a9 Mouse disodium selenite increases expression ISO SLC6A9 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of SLC6A9 mRNA CTD PMID:24383545 Slc6a9 Mouse disulfiram multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC6A9 mRNA CTD PMID:24690739 Slc6a9 Mouse diuron increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Diuron results in increased expression of SLC6A9 mRNA CTD PMID:21551480 Slc6a9 Mouse doxorubicin decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC6A9 mRNA CTD PMID:29803840 Slc6a9 Mouse endosulfan increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SLC6A9 mRNA CTD PMID:29391264 Slc6a9 Mouse endosulfan increases expression ISO SLC6A9 (Homo sapiens) 6480464 Endosulfan results in increased expression of SLC6A9 mRNA CTD PMID:30090376 Slc6a9 Mouse enniatin increases expression ISO SLC6A9 (Homo sapiens) 6480464 enniatins results in increased expression of SLC6A9 mRNA CTD PMID:36016515 Slc6a9 Mouse epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of SLC6A9 mRNA CTD PMID:35436446 Slc6a9 Mouse ethanol increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Ethanol results in increased expression of SLC6A9 mRNA CTD PMID:20655511 Slc6a9 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC6A9 mRNA CTD PMID:30319688 Slc6a9 Mouse ethanol multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SLC6A9 mRNA CTD PMID:29432896 Slc6a9 Mouse fenofibrate increases expression ISO SLC6A9 (Homo sapiens) 6480464 Fenofibrate results in increased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse fenofibrate decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Fenofibrate results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse fipronil decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 fipronil results in decreased expression of SLC6A9 mRNA CTD PMID:23962444 Slc6a9 Mouse flavonoids decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of SLC6A9 mRNA CTD PMID:18035473 Slc6a9 Mouse flutamide increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Flutamide results in increased expression of SLC6A9 mRNA CTD PMID:24136188 Slc6a9 Mouse folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Slc6a9 Mouse gentamycin increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of SLC6A9 mRNA CTD PMID:33387578 Slc6a9 Mouse glycine betaine decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Betaine results in decreased expression of SLC6A9 mRNA CTD PMID:26391144 Slc6a9 Mouse glyphosate increases methylation ISO Slc6a9 (Rattus norvegicus) 6480464 Glyphosate results in increased methylation of SLC6A9 gene CTD PMID:31011160 Slc6a9 Mouse ibuprofen increases expression ISO SLC6A9 (Homo sapiens) 6480464 Ibuprofen results in increased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse ifosfamide decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Ifosfamide results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC6A9 mRNA CTD PMID:36331819 Slc6a9 Mouse iron dichloride decreases expression ISO SLC6A9 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of SLC6A9 mRNA CTD PMID:35984750 Slc6a9 Mouse L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene CTD PMID:20938992 Slc6a9 Mouse lead diacetate increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 lead acetate results in increased expression of SLC6A9 mRNA CTD PMID:11578147 Slc6a9 Mouse mercury dichloride increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Mercuric Chloride results in increased expression of SLC6A9 mRNA CTD PMID:16507785 Slc6a9 Mouse metformin increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Metformin results in increased expression of SLC6A9 mRNA CTD PMID:25596134 and PMID:31324951 Slc6a9 Mouse methamphetamine increases response to substance ISO SLC6A9 (Homo sapiens) 6480464 SLC6A9 gene SNP results in increased susceptibility to Methamphetamine CTD PMID:17582620 Slc6a9 Mouse methotrexate affects expression EXP 6480464 Methotrexate affects the expression of SLC6A9 mRNA CTD PMID:18502557 Slc6a9 Mouse mono(2-ethylhexyl) phthalate increases expression ISO SLC6A9 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of SLC6A9 mRNA CTD PMID:36695872 Slc6a9 Mouse N(4)-hydroxycytidine decreases expression EXP 6480464 N(4)-hydroxycytidine results in decreased expression of SLC6A9 mRNA CTD PMID:37748715 Slc6a9 Mouse N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA] CTD PMID:25566086 Slc6a9 Mouse N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA CTD PMID:25566086 Slc6a9 Mouse N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA CTD PMID:22776087 Slc6a9 Mouse N-methyl-4-phenylpyridinium increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA CTD PMID:28801915 Slc6a9 Mouse N-nitrosodiethylamine multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA CTD PMID:20360939 Slc6a9 Mouse nefazodone increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 nefazodone results in increased expression of SLC6A9 mRNA CTD PMID:24136188 Slc6a9 Mouse nimesulide increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 nimesulide results in increased expression of SLC6A9 mRNA CTD PMID:24136188 Slc6a9 Mouse nobiletin increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 nobiletin results in increased expression of SLC6A9 mRNA CTD PMID:23321314 Slc6a9 Mouse nobiletin increases expression ISO SLC6A9 (Homo sapiens) 6480464 nobiletin results in increased expression of SLC6A9 mRNA CTD PMID:23321314 Slc6a9 Mouse okadaic acid increases expression ISO SLC6A9 (Homo sapiens) 6480464 Okadaic Acid results in increased expression of SLC6A9 mRNA CTD PMID:38832940 Slc6a9 Mouse oxaliplatin decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 oxaliplatin results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 Slc6a9 Mouse oxaliplatin multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 Slc6a9 Mouse oxycodone decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Oxycodone results in decreased expression of SLC6A9 mRNA CTD PMID:23439660 Slc6a9 Mouse ozone multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA CTD PMID:18636392 Slc6a9 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC6A9 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC6A9 mRNA CTD PMID:34911549 Slc6a9 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLC6A9 mRNA CTD PMID:17562736 Slc6a9 Mouse paracetamol increases expression ISO SLC6A9 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC6A9 mRNA CTD PMID:29067470 Slc6a9 Mouse paracetamol decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC6A9 mRNA CTD PMID:26690555 Slc6a9 Mouse paraquat increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Paraquat results in increased expression of SLC6A9 mRNA CTD PMID:17077588 and PMID:18198484 Slc6a9 Mouse pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of SLC6A9 mRNA CTD PMID:23892564 Slc6a9 Mouse perfluorononanoic acid increases expression ISO SLC6A9 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC6A9 mRNA CTD PMID:32588087 Slc6a9 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of SLC6A9 mRNA more ... CTD PMID:33483757 and PMID:36331819 Slc6a9 Mouse perfluorooctane-1-sulfonic acid increases expression ISO SLC6A9 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of SLC6A9 mRNA CTD PMID:36864359 Slc6a9 Mouse perfluorooctanoic acid increases expression ISO SLC6A9 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SLC6A9 mRNA CTD PMID:37302725 Slc6a9 Mouse phenethyl caffeate multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA CTD PMID:20360939 Slc6a9 Mouse phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC6A9 mRNA] CTD PMID:19482888 Slc6a9 Mouse phenobarbital decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of SLC6A9 mRNA CTD PMID:30047161 Slc6a9 Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SLC6A9 mRNA CTD PMID:23091169 Slc6a9 Mouse phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SLC6A9 mRNA CTD PMID:19482888 Slc6a9 Mouse phorone affects expression ISO Slc6a9 (Rattus norvegicus) 6480464 phorone affects the expression of SLC6A9 mRNA CTD PMID:18198479 Slc6a9 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC6A9 mRNA CTD PMID:18301758 Slc6a9 Mouse pregnenolone 16alpha-carbonitrile decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A9 mRNA CTD PMID:19162173 Slc6a9 Mouse pyrazinecarboxamide decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Pyrazinamide results in decreased expression of SLC6A9 mRNA CTD PMID:22431067 Slc6a9 Mouse rifampicin increases expression ISO SLC6A9 (Homo sapiens) 6480464 Rifampin results in increased expression of SLC6A9 mRNA CTD PMID:27199754 Slc6a9 Mouse rotenone increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Rotenone results in increased expression of SLC6A9 mRNA CTD PMID:28374803 Slc6a9 Mouse rotenone decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Rotenone results in decreased expression of SLC6A9 mRNA CTD PMID:29955902 Slc6a9 Mouse S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO SLC6A9 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of SLC6A9 mRNA CTD PMID:33725128 Slc6a9 Mouse sevoflurane affects expression ISO Slc6a9 (Rattus norvegicus) 6480464 sevoflurane affects the expression of SLC6A9 mRNA CTD PMID:15967596 Slc6a9 Mouse silicon dioxide increases expression ISO SLC6A9 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLC6A9 mRNA CTD PMID:25895662 Slc6a9 Mouse silicon dioxide decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of SLC6A9 mRNA CTD PMID:25351596 Slc6a9 Mouse sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SLC6A9 mRNA CTD PMID:31170414 Slc6a9 Mouse sodium arsenite decreases expression ISO SLC6A9 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC6A9 mRNA CTD PMID:34032870 Slc6a9 Mouse sodium arsenite increases expression ISO SLC6A9 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC6A9 mRNA CTD PMID:29301061 and PMID:38568856 Slc6a9 Mouse sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of SLC6A9 mRNA CTD PMID:27862939 Slc6a9 Mouse sotorasib multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC6A9 mRNA CTD PMID:36139627 Slc6a9 Mouse sunitinib increases expression ISO SLC6A9 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC6A9 mRNA CTD PMID:31533062 Slc6a9 Mouse tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of SLC6A9 mRNA CTD PMID:25123088 Slc6a9 Mouse tauroursodeoxycholic acid increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 ursodoxicoltaurine results in increased expression of SLC6A9 mRNA CTD PMID:15885361 Slc6a9 Mouse tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of SLC6A9 mRNA CTD PMID:28973375 Slc6a9 Mouse tetrachloromethane increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of SLC6A9 mRNA CTD PMID:31150632 Slc6a9 Mouse tetrachloromethane multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC6A9 mRNA] CTD PMID:31150632 Slc6a9 Mouse thapsigargin increases expression ISO SLC6A9 (Homo sapiens) 6480464 Thapsigargin results in increased expression of SLC6A9 mRNA CTD PMID:22378314 Slc6a9 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of SLC6A9 mRNA CTD PMID:29264374 Slc6a9 Mouse titanium dioxide increases expression ISO SLC6A9 (Homo sapiens) 6480464 titanium dioxide results in increased expression of SLC6A9 mRNA CTD PMID:34973136 Slc6a9 Mouse titanium dioxide increases methylation EXP 6480464 titanium dioxide results in increased methylation of SLC6A9 gene CTD PMID:35295148 Slc6a9 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of SLC6A9 gene CTD PMID:35295148 Slc6a9 Mouse toluene affects expression ISO Slc6a9 (Rattus norvegicus) 6480464 Toluene affects the expression of SLC6A9 mRNA CTD PMID:18653662 Slc6a9 Mouse topotecan multiple interactions ISO Slc6a9 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 Slc6a9 Mouse topotecan decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Topotecan results in decreased expression of SLC6A9 mRNA CTD PMID:25729387 Slc6a9 Mouse trametinib multiple interactions ISO SLC6A9 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC6A9 mRNA CTD PMID:36139627 Slc6a9 Mouse trichloroethene increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of SLC6A9 mRNA CTD PMID:33387578 Slc6a9 Mouse triphenyl phosphate increases expression ISO Slc6a9 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of SLC6A9 mRNA CTD PMID:30589522 Slc6a9 Mouse triptonide decreases expression EXP 6480464 triptonide results in decreased expression of SLC6A9 mRNA CTD PMID:33045310 Slc6a9 Mouse tris(2-butoxyethyl) phosphate affects expression ISO SLC6A9 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC6A9 mRNA CTD PMID:29024780 Slc6a9 Mouse troglitazone decreases expression ISO Slc6a9 (Rattus norvegicus) 6480464 troglitazone results in decreased expression of SLC6A9 mRNA CTD PMID:25596134 Slc6a9 Mouse trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of SLC6A9 mRNA CTD PMID:35537566 Slc6a9 Mouse tunicamycin increases expression ISO SLC6A9 (Homo sapiens) 6480464 Tunicamycin results in increased expression of SLC6A9 mRNA CTD PMID:22378314 and PMID:29453283 Slc6a9 Mouse urethane decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Urethane results in decreased expression of SLC6A9 mRNA CTD PMID:28818685 Slc6a9 Mouse vanadium atom decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Vanadium results in decreased expression of SLC6A9 mRNA CTD PMID:19000753 Slc6a9 Mouse vanadium(0) decreases expression ISO SLC6A9 (Homo sapiens) 6480464 Vanadium results in decreased expression of SLC6A9 mRNA CTD PMID:19000753
(+)-schisandrin B (ISO) (1->4)-beta-D-glucan (EXP) 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (ISO) 1,2-dimethylhydrazine (EXP) 17alpha-ethynylestradiol (EXP) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (ISO) 2-butoxyethanol (EXP) 3,3',4,4'-tetrachlorobiphenyl (EXP) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxyphenyl retinamide (EXP) 6-propyl-2-thiouracil (ISO) 8-Br-cAMP (ISO) acetamide (ISO) adefovir pivoxil (ISO) aflatoxin B1 (EXP,ISO) Aflatoxin B2 alpha (ISO) amitrole (ISO) amphetamine (EXP) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) arsenous acid (ISO) atrazine (ISO) benzamide (ISO) benzo[a]pyrene (EXP,ISO) beta-lapachone (ISO) bis(2-chloroethyl) sulfide (EXP) bis(2-ethylhexyl) phthalate (EXP) bisphenol A (EXP,ISO) bisphenol F (EXP,ISO) butan-1-ol (ISO) cadmium dichloride (ISO) cannabidiol (EXP,ISO) carbon nanotube (EXP) casticin (EXP) chlordecone (EXP) chloroacetaldehyde (ISO) chlorpyrifos (EXP) choline (EXP) cidofovir anhydrous (ISO) ciguatoxin CTX1B (EXP) cisplatin (ISO) clobetasol (EXP) clodronic acid (ISO) clofibric acid (ISO) cobalt dichloride (ISO) copper atom (ISO) copper(0) (ISO) coumarin (ISO) Cuprizon (ISO) cyclosporin A (ISO) DDE (ISO) decabromodiphenyl ether (ISO) dexamethasone (ISO) diarsenic trioxide (ISO) diazinon (ISO) dibenzo[a,l]pyrene (ISO) dibutyl phthalate (ISO) dichlorine (ISO) diclofenac (EXP) dioxygen (EXP,ISO) disodium selenite (ISO) disulfiram (ISO) diuron (ISO) doxorubicin (ISO) endosulfan (ISO) enniatin (ISO) epoxiconazole (EXP) ethanol (EXP,ISO) fenofibrate (ISO) fipronil (ISO) flavonoids (ISO) flutamide (ISO) folic acid (EXP) gentamycin (ISO) glycine betaine (ISO) glyphosate (ISO) ibuprofen (ISO) ifosfamide (ISO) inulin (EXP) iron dichloride (ISO) L-methionine (EXP) lead diacetate (ISO) mercury dichloride (ISO) metformin (ISO) methamphetamine (ISO) methotrexate (EXP) mono(2-ethylhexyl) phthalate (ISO) N(4)-hydroxycytidine (EXP) N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal (EXP) N-methyl-4-phenylpyridinium (EXP,ISO) N-nitrosodiethylamine (ISO) nefazodone (ISO) nimesulide (ISO) nobiletin (ISO) okadaic acid (ISO) oxaliplatin (ISO) oxycodone (ISO) ozone (EXP,ISO) paracetamol (EXP,ISO) paraquat (ISO) pentachlorophenol (EXP) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (EXP,ISO) perfluorooctanoic acid (ISO) phenethyl caffeate (ISO) phenobarbital (EXP,ISO) phorone (ISO) pirinixic acid (EXP) pregnenolone 16alpha-carbonitrile (ISO) pyrazinecarboxamide (ISO) rifampicin (ISO) rotenone (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) sevoflurane (ISO) silicon dioxide (ISO) sodium arsenite (EXP,ISO) sodium fluoride (EXP) sotorasib (ISO) sunitinib (ISO) tamoxifen (EXP) tauroursodeoxycholic acid (ISO) tetrachloroethene (EXP) tetrachloromethane (ISO) thapsigargin (ISO) titanium dioxide (EXP,ISO) toluene (ISO) topotecan (ISO) trametinib (ISO) trichloroethene (ISO) triphenyl phosphate (ISO) triptonide (EXP) tris(2-butoxyethyl) phosphate (ISO) troglitazone (ISO) trovafloxacin (EXP) tunicamycin (ISO) urethane (ISO) vanadium atom (ISO) vanadium(0) (ISO)
Slc6a9 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 117,692,240 - 117,726,502 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 117,691,703 - 117,732,395 (+) Ensembl GRCm39 Ensembl GRCm38 4 117,835,258 - 117,869,305 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 117,834,506 - 117,875,198 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 117,507,863 - 117,541,910 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 117,333,190 - 117,367,237 (+) NCBI MGSCv36 mm8 Celera 4 116,550,328 - 116,584,414 (+) NCBI Celera Cytogenetic Map 4 D1 NCBI cM Map 4 53.62 NCBI
SLC6A9 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 43,996,483 - 44,031,462 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 43,991,500 - 44,031,467 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 44,462,155 - 44,497,134 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 44,234,742 - 44,269,721 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 44,132,286 - 44,152,090 NCBI Celera 1 42,745,693 - 42,780,672 (-) NCBI Celera Cytogenetic Map 1 p34.1 NCBI HuRef 1 42,577,665 - 42,612,669 (-) NCBI HuRef CHM1_1 1 44,578,322 - 44,613,386 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 43,859,929 - 43,902,553 (-) NCBI T2T-CHM13v2.0
Slc6a9 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 136,660,022 - 136,694,173 (+) NCBI GRCr8 mRatBN7.2 5 131,374,562 - 131,408,733 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 131,374,542 - 131,408,728 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 134,079,676 - 134,113,767 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 135,834,289 - 135,868,384 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 135,856,719 - 135,890,810 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 136,669,674 - 136,703,702 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 136,669,674 - 136,703,697 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 140,458,723 - 140,492,751 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 138,300,869 - 138,334,893 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 138,313,795 - 138,339,599 (+) NCBI Celera 5 129,922,904 - 129,957,106 (+) NCBI Celera Cytogenetic Map 5 q36 NCBI
Slc6a9 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955537 3,520,516 - 3,550,022 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955537 3,520,516 - 3,549,492 (-) NCBI ChiLan1.0 ChiLan1.0
SLC6A9 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 182,778,098 - 182,813,151 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 181,919,460 - 181,954,476 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 43,298,326 - 43,333,345 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 44,669,364 - 44,704,882 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 44,664,839 - 44,704,882 (-) Ensembl panpan1.1 panPan2
SLC6A9 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 15 16,235,342 - 16,267,161 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 15 16,235,482 - 16,267,933 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 15 16,356,708 - 16,389,086 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 15 16,390,376 - 16,422,650 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 15 16,390,493 - 16,422,543 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 15 16,189,225 - 16,221,582 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 15 16,257,816 - 16,290,585 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 15 16,330,949 - 16,363,315 (+) NCBI UU_Cfam_GSD_1.0
Slc6a9 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 59,487,760 - 59,520,209 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936474 25,313,201 - 25,345,053 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936474 25,312,544 - 25,344,993 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SLC6A9 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 167,268,963 - 167,301,599 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 167,267,193 - 167,301,598 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 154,781,274 - 154,783,428 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC6A9 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 88,774,354 - 88,809,726 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 88,774,339 - 88,808,669 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 28,117,914 - 28,153,448 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Slc6a9
.
Predicted Target Of
Count of predictions: 4079 Count of miRNA genes: 848 Interacting mature miRNAs: 1144 Transcripts: ENSMUST00000030269, ENSMUST00000063857, ENSMUST00000123994, ENSMUST00000132043, ENSMUST00000135769, ENSMUST00000136476, ENSMUST00000149168, ENSMUST00000151316, ENSMUST00000163288, ENSMUST00000169885, ENSMUST00000169990, ENSMUST00000170733 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
12904006 Cfq1_m conditioned fear QTL 1 (mouse) 4 117177646 120107755 Mouse 13824982 Svwq1_m seminal vesicle weight QTL 1 (mouse) 4 89888237 118857197 Mouse 11532714 Sluc43_m susceptibility to lung cancer 43 (mouse) 4 46642108 123127211 Mouse 10047132 Albq19_m albuminuria QTL 19 (mouse) Not determined 4 112824389 146824389 Mouse 12904002 Opfaq9_m open field activity QTL 9 (mouse) 4 92975790 126975790 Mouse 4141623 W6q13_m weight 6 weeks QTL 13 (mouse) Not determined 88982069 140468203 Mouse 12910797 Pwgrq4_m pre-weaning growth rate QTL 4 (mouse) 4 105835310 141433838 Mouse 25314312 Syncl2_m synaptonemal complex length 2 (mouse) 4 65718237 146584457 Mouse 1357726 Lnopy1_m lens opacity 1 (mouse) Not determined 4 85428838 119429037 Mouse 12910794 Pwbwq8_m post-weaning body weight QTL 8 (mouse) 4 105835310 141433838 Mouse 14696689 Gdq2_m grooming duration QTL 2, females (mouse) 4 100857197 124893793 Mouse 1300743 Skull6_m skull morphology 6 (mouse) Not determined 4 111009051 145009280 Mouse 1301382 Arvm2_m autoimmune renal vasculitis 2 (mouse) Not determined 4 107791564 141791756 Mouse 12910813 Pwbwq4_m pre-weaning body weight QTL 4 (mouse) 4 105835310 141433838 Mouse 4141093 W3q17_m weight 3 weeks QTL 17 (mouse) Not determined 88982069 140468203 Mouse 12910808 Pwbwq9_m post-weaning body weight QTL 9 (mouse) 4 105835310 141433838 Mouse 27095939 Ulnl9_m ulna length 9, 16 week (mouse) 4 65318237 118857197 Mouse 11567249 Elorr3_m ethanol induced loss of righting response 3 (mouse) 4 3722677 156268235 Mouse 4142493 Femwf13_m femur work to failure 13 (mouse) Not determined 116154678 150154782 Mouse 1301815 Sles2_m systemic lupus erythmatosus suppressor 2 (mouse) Not determined 4 94957579 150676858 Mouse 1300663 Start2_m startle response 2 (mouse) Not determined 4 107264957 141265153 Mouse 1300918 Stheal4_m soft tissue heal 4 (mouse) Not determined 4 89969627 123969747 Mouse 1301556 Cd4vts1_m CD4 virgin T cell subset 1 (mouse) Not determined 4 85428838 119429037 Mouse 1301823 Bmd7_m bone mineral density 7 (mouse) Not determined 4 88982069 151654550 Mouse 4141330 Iva1_m isovaleric acid smelling 1 (mouse) Not determined 117071971 120723203 Mouse 1302078 Sluc21_m susceptibility to lung cancer 21 (mouse) Not determined 4 117401141 151401275 Mouse 10412072 Ssen1_m suseptibility to Sendai virus 1 (mouse) Not determined 4 109658132 133154782 Mouse 1301930 Papg1_m pulmonary adenoma progression 1 (mouse) Not determined 4 85781167 119781279 Mouse 13208562 Wght7_m weight 7 (mouse) 4 90888237 148084457 Mouse 13208565 Bmiq6_m body mass index QTL 6 (mouse) 4 110857197 125893793 Mouse 1300655 Nidds_m non-insulin-dependent diabetes mellitus in SJL (mouse) Not determined 4 115030777 129465915 Mouse 1300781 Lith8_m lithogenic gene 8 (mouse) Not determined 4 107264957 141265153 Mouse 39128212 Lwq21_m liver weight QTL 21 (mouse) 4 88982069 140468203 Mouse 1300689 Dob1_m Dietary obesity 1 (mouse) Body weight 4 101574601 123127211 Mouse 27226716 Metcl2_m metatarsal-calcaneal length 2, 5 week (mouse) 4 88118237 118557197 Mouse 1301847 Fecq2_m fecundity QTL 2 (mouse) Not determined 4 100071971 134072206 Mouse 26884445 Sklq7_m skull length QTL 7, 10 week (mouse) 4 68018237 150884457 Mouse 1301597 Anxty_m anxiety (mouse) Not determined 4 74137574 128009280 Mouse 26884437 Sklq13_m skull length QTL 13, 16 week (mouse) 4 57700000 155684457 Mouse 4141549 W10q10_m weight 10 weeks QTL 10 (mouse) Not determined 88982069 140468203 Mouse 1357895 Ctrcts_m cataract severity (mouse) Not determined 4 45709925 138342753 Mouse 1300809 Ccrs2_m corpus callosum hemisphere surface size 2 (mouse) Not determined 4 107264957 141265153 Mouse 1301106 Skts7_m skin tumor susceptibility 7 (mouse) Not determined 4 100071971 134072206 Mouse 1301233 Sbw2_m splenomegaly-NZB x NZW 2 (mouse) Not determined 4 94957579 128009280 Mouse 10755520 Rbc1_m red blood cell count 1 (mouse) 4 108477692 142477692 Mouse 10755521 Hct1_m hematocrit 1 (mouse) 4 108477692 142477692 Mouse 10755522 Hgb1_m hemoglobin 1 (mouse) 4 108477692 142477692 Mouse 27095924 Pglq2_m pelvic girdle length QTL 2, 5 week (mouse) 4 69118237 130727311 Mouse 1301118 Bbaa23_m B.burgdorferi-associated arthritis 23 (mouse) Not determined 4 85781167 119781279 Mouse 15039368 Nmrs19_m NAFLD-associated magnetic resonance shift 19 (mouse) 4 90882780 124882780 Mouse 27095917 Scvln14_m sacral vertebrae length 2, 16 week (mouse) 4 68018237 130277062 Mouse 1301731 Cafq2_m caffeine metabolism QTL 2 (mouse) Not determined 4 94732255 128732454 Mouse 4141900 Skts-fp1_m skin tumor susceptibility in FVB and PWK 1 (mouse) Not determined 4 53550839 124055180 Mouse 15039382 Ltgq7_m liver triglyceride QTL 7 (mouse) 4 105705794 139705794 Mouse 15039377 Bw45_m body weight QTL 45 (mouse) 4 105705794 139705794 Mouse 1300839 Dyscalc2_m dystrophic cardiac calcinosis 2 (mouse) Not determined 4 111009051 145009280 Mouse 12880433 Fgf23lq1_m FGF23 serum level QTL 1 (mouse) 4 101157197 135157197 Mouse 4141001 Tgq17_m triglyceride QTL 17 (mouse) Not determined 112523489 146523489 Mouse 1300580 Lbw2_m lupus NZB x NZW 2 (mouse) Not determined 4 98545539 128009280 Mouse 15039378 Adip30_m adiposity 30 (mouse) 4 105705794 139705794 Mouse 26884449 Sklq2_m skull length QTL 2, 5 week (mouse) 4 36700000 128993793 Mouse 27095905 Scvln3_m sacral vertebrae length 2, 5 week (mouse) 4 55600000 128993793 Mouse 1357800 Tgq3_m triglyceride QTL 3 (mouse) Not determined 4 107055093 141055180 Mouse 15039385 Mvlq3_m macrovesicular liver lesion QTL 3 (mouse) 4 112182386 146182386 Mouse 11553870 Cmmm_m carcinoma modifier of MSM (mouse) 4 90590668 124590781 Mouse 1301996 Mmtg2_m modifier of mammary tumor growth 2 (mouse) Not determined 4 116270979 124055180 Mouse
Slc6a9
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 4 117,843,028 - 117,843,130 UniSTS GRCm38 MGSCv37 4 117,515,633 - 117,515,735 UniSTS GRCm37 Celera 4 116,558,101 - 116,558,203 UniSTS Cytogenetic Map 4 D2.1 UniSTS
RH141917
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 4 117,869,048 - 117,869,226 UniSTS GRCm38 MGSCv37 4 117,541,653 - 117,541,831 UniSTS GRCm37 Celera 4 116,584,157 - 116,584,335 UniSTS Cytogenetic Map 4 D2.1 UniSTS
Glyt1
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 4 117,868,954 - 117,869,158 UniSTS GRCm38 MGSCv37 4 117,541,559 - 117,541,763 UniSTS GRCm37 Celera 4 116,584,063 - 116,584,267 UniSTS Cytogenetic Map 4 D2.1 UniSTS cM Map 4 52.0 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
Ensembl Acc Id:
ENSMUST00000030269 ⟹ ENSMUSP00000030269
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,692,248 - 117,726,502 (+) Ensembl GRCm38.p6 Ensembl 4 117,835,051 - 117,869,305 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000063857 ⟹ ENSMUSP00000066102
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,691,703 - 117,726,493 (+) Ensembl GRCm38.p6 Ensembl 4 117,834,506 - 117,869,296 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000123994 ⟹ ENSMUSP00000127806
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,712,689 - 117,714,624 (+) Ensembl GRCm38.p6 Ensembl 4 117,855,492 - 117,857,427 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000132043 ⟹ ENSMUSP00000122676
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,706,390 - 117,721,201 (+) Ensembl GRCm38.p6 Ensembl 4 117,849,193 - 117,864,004 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000135769
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,712,741 - 117,713,224 (+) Ensembl GRCm38.p6 Ensembl 4 117,855,544 - 117,856,027 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000136476
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,692,635 - 117,714,368 (+) Ensembl GRCm38.p6 Ensembl 4 117,835,438 - 117,857,171 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000149168 ⟹ ENSMUSP00000129359
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,692,530 - 117,732,393 (+) Ensembl GRCm38.p6 Ensembl 4 117,835,333 - 117,875,196 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000151316 ⟹ ENSMUSP00000118372
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,692,192 - 117,700,306 (+) Ensembl GRCm38.p6 Ensembl 4 117,834,995 - 117,843,109 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000163288 ⟹ ENSMUSP00000127289
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,706,567 - 117,725,622 (+) Ensembl GRCm38.p6 Ensembl 4 117,849,370 - 117,868,425 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000169885 ⟹ ENSMUSP00000127093
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,692,594 - 117,725,534 (+) Ensembl GRCm38.p6 Ensembl 4 117,835,397 - 117,868,337 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000169990 ⟹ ENSMUSP00000127203
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,706,396 - 117,721,201 (+) Ensembl GRCm38.p6 Ensembl 4 117,849,199 - 117,864,004 (+) Ensembl
Ensembl Acc Id:
ENSMUST00000170733
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 4 117,731,279 - 117,732,395 (+) Ensembl GRCm38.p6 Ensembl 4 117,874,082 - 117,875,198 (+) Ensembl
RefSeq Acc Id:
NM_001355175 ⟹ NP_001342104
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 117,706,547 - 117,726,501 (+) NCBI GRCm38 4 117,849,350 - 117,869,304 (+) NCBI
Sequence:
AGTGTCGTGCTGGAGCTGGCAGAGGTGTGAATGATCGGTGGAGACACGCGTGCTGCGAGTGCTCATCCCGGGATGGCTTCGGCTCAAGGACCTGTGGCCACCCCTTCCCCAGAACAGAATGGTGCTGT
hide sequence
RefSeq Acc Id:
NM_001369016 ⟹ NP_001355945
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 117,692,807 - 117,726,501 (+) NCBI GRCm38 4 117,835,610 - 117,869,304 (+) NCBI
Sequence:
ATAGCGTTTGCTTGCGGGTATCTGTGGCTAAGAGTGTGAGTGCTCGCACTGGGATGTCTGTCTCGCCGCGAAGGTCTGGCTCTTGAGGCCTGTTGTCTGAAAGGCACTGAACGCAAGAGTCTGCAAGT
hide sequence
RefSeq Acc Id:
NM_001369017 ⟹ NP_001355946
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 117,712,744 - 117,726,501 (+) NCBI GRCm38 4 117,855,547 - 117,869,304 (+) NCBI
Sequence:
AGCCTGAGAGGAATGGCAAGGGTTTAGAGGGGTTAGGGGGCTCTTGGCTCAGGCTCCCTCCTCA
hide sequence
RefSeq Acc Id:
NM_008135 ⟹ NP_032161
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 117,692,455 - 117,726,502 (+) NCBI GRCm38 4 117,835,258 - 117,869,305 (+) ENTREZGENE MGSCv37 4 117,507,863 - 117,541,910 (+) RGD Celera 4 116,550,328 - 116,584,414 (+) RGD cM Map 4 ENTREZGENE
Sequence:
AAGCCTTCTTCACTCTCCAAACTTTCACCAAACTCTTAGCCCCCGCCTCCCCGAAACCAAAACA
hide sequence
RefSeq Acc Id:
XM_036163684 ⟹ XP_036019577
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 117,692,240 - 117,726,502 (+) NCBI
Sequence:
GCAGAGAGGCGAAGGAGAAGGGGACTCCTTTGCCGAGCCCCACTCCCAGGGGTTCGTGAGGATC
hide sequence
RefSeq Acc Id:
XR_867807
Type:
NON-CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 4 117,706,363 - 117,726,502 (+) NCBI GRCm38 4 117,849,289 - 117,869,305 (+) NCBI
Sequence:
CAAGGGAACACCACATCAGCCCCATGCCTCGTTCTCCAGCTCCGGAGCACCCTCGCTGGGCTGCATCAGGACTGGCCAGAGGGGGAGGGTCAGGGAGGGGGTAGGCTGAGCTTGGGGAGGAGATGAGG
hide sequence
RefSeq Acc Id:
NP_032161 ⟸ NM_008135
- Peptide Label:
isoform 1
- UniProtKB:
E9Q3V0 (UniProtKB/TrEMBL)
- Sequence:
MVGKGAKGMLNGAVPSEATKKDQNLTRGNWGNQIEFVLTSVGYAVGLGNVWRFPYLCYRNGGGAFMFPYFIMLIFCGIPLFFMELSFGQFASQGCLGVWRISPMFKGVGYGMMVVSTYIGIYYNVVIC
hide sequence
RefSeq Acc Id:
NP_001355945 ⟸ NM_001369016
- Peptide Label:
isoform 1
- UniProtKB:
E9Q3V0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
NP_001342104 ⟸ NM_001355175
- Peptide Label:
isoform 2
- UniProtKB:
E9Q3V0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
NP_001355946 ⟸ NM_001369017
- Peptide Label:
isoform 3 precursor
- UniProtKB:
E9Q517 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSMUSP00000127289 ⟸ ENSMUST00000163288
Ensembl Acc Id:
ENSMUSP00000122676 ⟸ ENSMUST00000132043
Ensembl Acc Id:
ENSMUSP00000118372 ⟸ ENSMUST00000151316
Ensembl Acc Id:
ENSMUSP00000129359 ⟸ ENSMUST00000149168
Ensembl Acc Id:
ENSMUSP00000127806 ⟸ ENSMUST00000123994
Ensembl Acc Id:
ENSMUSP00000030269 ⟸ ENSMUST00000030269
Ensembl Acc Id:
ENSMUSP00000066102 ⟸ ENSMUST00000063857
Ensembl Acc Id:
ENSMUSP00000127093 ⟸ ENSMUST00000169885
Ensembl Acc Id:
ENSMUSP00000127203 ⟸ ENSMUST00000169990
RefSeq Acc Id:
XP_036019577 ⟸ XM_036163684
- Peptide Label:
isoform X1
RGD ID: 6836413 Promoter ID: MM_KWN:39261 Type: CpG-Island SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: Liver, MEF_B4 Transcripts: ENSMUST00000063857, OTTMUST00000019609, OTTMUST00000019610, OTTMUST00000019612, OTTMUST00000019613, OTTMUST00000019616 Position: Mouse Assembly Chr Position (strand) Source MGSCv36 4 117,507,819 - 117,508,319 (+) MPROMDB
RGD ID: 6847855 Promoter ID: MM_ACW:35477 Type: CpG-Island SO ACC ID: SO:0000170 Source: MPROMDB Tissues & Cell Lines: Kidney Transcripts: SLC6A9.HSEP07-UNSPLICED Position: Mouse Assembly Chr Position (strand) Source MGSCv36 4 117,540,226 - 117,540,726 (+) MPROMDB
RGD ID: 6884378 Promoter ID: EPDNEW_M5640 Type: initiation region Name: Slc6a9_1 Description: Mus musculus solute carrier family 6 (neurotransmitter transporter,glycine), member 9 , transcript variant 1, mRNA. SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Mouse Assembly Chr Position (strand) Source GRCm38 4 117,835,321 - 117,835,381 EPDNEW
